An investigation for investors in NASDAQ:ALXN shares over potential securities laws violations by Alexion Pharmaceuticals, Inc. was announced and NASDAQ:ALXN stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 06/09/2017 --Alexion Pharmaceuticals, Inc is under investigation over potential securities laws violations. The investigation was announced on behalf of investors in NASDAQ:ALX in connection with certain financial statements made by Alexion Pharmaceuticals, Inc.

Investors who purchased shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) concerning whether certain statements by Alexion Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On May 8, 2017, Alexion Pharmaceuticals' São Paulo offices were raided as part of an investigation into the Company's business practices. According to local law enforcement officials, Alexion Pharmaceuticals, Inc. may be involved in a scheme wherein the Company, with the aid of a local patient association, subsidized lawsuits for patients to get access to the Company's drug via Brazil's national health system. Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) declined on May 26, 2017 to $96.18 per share.

On June 8, 2017, NASDAQ:ALXN shares closed at $102.92 per share.

Those who purchased shares of Alexion Pharmaceuticals, Inc. have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com